ABSTRACT
Objective:To investigate the clinical efficacy of neuroendoscopic hematoma removal versus soft channel drainage in the treatment of chronic subdural hematoma (CSDH) and their effects on neurological function and quality of life. Methods:The clinical data of 97 patients with CSDH who received treatment between February 2018 and December 2019 were retrospectively analyzed. These patients were divided into group A ( n = 48, soft channel drainage) and group B ( n = 49, neuroendoscopic hematoma removal) according to different surgical methods. Clinical indicators, neurological function, quality of life, and incidence of complications were compared between groups A and B. Results:Operative time, length of hospital stay, and latency to hematoma disappearance in group B were (31.3 ± 2.18) minutes, (8.16 ± 1.32) days, (7.45 ± 1.49) days, which were significantly shorter than those in group A [(35.15 ± 4.32) minutes, (13.18 ± 1.56) days, (11.32 ± 1.88) days, t = 5.53, 17.12, 11.25, all P < 0.001]. At 3 months after surgery, the score of each dimension of SF-36 in each group was increased. The scores of physiological functioning, bodily pain, mental health, general health perceptions, social role functioning, vitality, role limitations due to emotional health, role limitations due to physical health in group B were (84.94 ± 7.25) points, (84.02 ± 6.29) points, (82.85 ± 8.16) points, (84.36 ± 9.15) points, (83.51 ± 10.39) points, (82.68 ± 8.36) points, (84.93 ± 10.15) points, (86.12 ± 9.13) points, which were significantly higher than those in group A [(62.68 ± 5.47) points, (71.39 ± 7.42) points, (69.51 ± 6.39) points, (72.68 ± 7.36) points, (72.81 ± 8.15) points, (73.12 ± 10.13) points, (77.91 ± 9.52) points, (75.32 ± 7.51) points, t = 19.82, 18.34, 19.75, 16.71, 17.94, 20.57, 18.22, 16.44, all P < 0.001]. At 7 days after surgery, neurotrophic factor, neuron specific enolase, hydrogen sulfide and S100B protein levels in group B were (42.53 ± 6.09) μg/L, (6.52 ± 2.79) μg/L, (203.17 ± 15.03) μmol/L, (0.25 ± 0.05) μg/L, respectively, which were significantly lower than those in group A [(67.38 ± 7.42) μg/L, (9.18 ± 2.27) μg/L, (242.79 ± 14.08) μmol/L, (0.36 ± 0.07) μg/L, t = 17.94, 5.12, 13.33, 8.86, all P < 0.001]. There was no significant difference in the incidence of complications between group B and group A [8.16% (4/49) vs. 18.75% (9/48), χ2 = 2.22, P = 0.136]. Conclusion:Compared with soft channel drainage, neuroendoscopic hematoma removal can better improve clinical indicators, neurological function, and quality of life in patients with CSDH, and is highly safe Neuroendoscopic hematoma removal is of certain clinical application value and innovation.
ABSTRACT
Objective To explore the curative efficacy of minimally invasive treatment for chronic subdural hematoma in elderly patients. Methods From February 2005 to February 2008, the clinical data of 20 elderly pa-tients suffered from chronic subdural hematoma were analyzed retrospectively. The patients were all treated by mini-mally invasive operations, along with the supportive treatment for repnsition of the brain. Results The hematomas (mean volume, 100 ml) were all cleared away postoperation. Brain reposition was obtained 24 hours ～ 7 days(mean, 3 days) after operations. All patients were cured to discharge. 20 patients were followed up for 3 ～ 12 months (mean,7 months). According to the activities of daily living (ADL) grading system, 16 patients were classified as normal, and 4 independent. Follow-up examination with CT scans in 16 patients showed 13 cases of normal findings, 2 cases of brain atrophy, and 1 mild subdural effusion. Conclusion Minimally invasive evacuation of hematoma is suited to elderly patients with chronic subdural hematoma,providing a satisfactory effect and a low recurrence rate.
ABSTRACT
Objective To evaluate the dfect of micro-invasive evacuation for treatment of cerebral hemorrhage.Methods Eighty patients with cerebral hemorrhage were treated by the micro-invasive surgery.Results The hematoma was evacuated between 1～5 days in 55 cases,7 dyas in 24 cases and 14 days in 1 case.The total effeetive rate was 81%.Seyen cases died.Modified rankin scale(MRS)0～1 was found in 21 cases,MRS 2～3 was found in 44 cases,MRS 4～5 in 8 cases.Conclusion Compared with the medical conservative treatment,the microinvasive evacuation for treatment of brain hemorrhage could significantly reduce patients'hospitalization time,morbidity and mortality.At the same time indication are relatively extensive,complications are less.